You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

centanafadine sustained release

Showing 1 - 25 of 7,887
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Attention Deficit Disorder, ADHD Trial in New York (Centanafadine SR, Placebo)

Completed
Has Results
  • Attention Deficit Disorder
  • Attention Deficit Hyperactivity Disorder
  • Centanafadine SR
  • Placebo
  • New York, New York
    For additional information regarding sites, contact 844-687-8522
Feb 22, 2022

Attention Deficit Disorder, ADHD Trial in Culver City (Centanafadine SR)

Completed
  • Attention Deficit Disorder
  • Attention Deficit Hyperactivity Disorder
  • Centanafadine SR
  • Culver City, California
    For additional information regarding sites, contact 844-687-8522
Apr 1, 2022

Attention Deficit Disorder With Hyperactivity Trial in United States (CTN SR, Matching )

Completed
Has Results
  • Attention Deficit Disorder With Hyperactivity
  • CTN SR
  • Matching placebo
  • Newport Beach, California
  • +3 more
Oct 14, 2021

Attention Deficit Disorder, ADHD Trial in Orlando (Centanafadine SR, Placebo)

Completed
Has Results
  • Attention Deficit Disorder
  • Attention Deficit Hyperactivity Disorder
  • Centanafadine SR
  • Placebo
  • Orlando, Florida
    For additional information regarding sites, contact 844-687-8522
Sep 20, 2021

Binge-Eating Disorder Trial in United States (Centanafadine, Placebo)

Completed
  • Binge-Eating Disorder
  • Phoenix, Arizona
  • +24 more
Sep 29, 2022

ADHD Trial in New York (Centanafadine)

Completed
Has Results
  • Attention Deficit Hyperactivity Disorder
  • New York, New York
    For additional information regarding sites, contact 844-687-8522
Dec 19, 2022

Adult Attention-deficit Hyperactivity Disorder (ADHD) Trial in Melbourne (CTN SR1, CTN XR1, CTN XR2)

Terminated
  • Adult Attention-deficit Hyperactivity Disorder (ADHD)
  • CTN SR1
  • +3 more
  • Melbourne, Australia
    (unnamed)
Feb 15, 2022

Generalized Anxiety Disorder Trial in Beijing (Toludesvenlafaxine Hydrochloride Sustained-release Tablet 80mg,

Not yet recruiting
  • Generalized Anxiety Disorder
  • Toludesvenlafaxine Hydrochloride Sustained-release Tablet 80mg
  • +2 more
  • Beijing, China
    Peking University Sixth Hospital
Aug 1, 2023

MDD Trial in Austin (Centanafadine (328.8 mg), Escitalopram, Placebo)

Recruiting
  • Major Depressive Disorder
  • Centanafadine (328.8 mg)
  • +2 more
  • Austin, Texas
    For additional information regarding sites, contact 844-687-8522
Sep 14, 2022

Partial Seizure Trial in Tianjin (Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB), Brivaracetam sustained-release tablets

Active, not recruiting
  • Partial Seizure
  • Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB)
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Municipal People's Hospital
Jan 31, 2023

Oxycodone Sustained-release Tablets for Moderate to Severe

Recruiting
  • Cancer Pain
  • +2 more
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    Jul 24, 2023

    Crohn's Disease, Oral Ulcer Trial in Xi'an (Mesalazine Sustained-Release Tablets, Riboflavin Sodium Phosphate Injection)

    Withdrawn
    • Crohn's Disease
    • Oral Ulcer
    • Mesalazine Sustained-Release Tablets
    • Riboflavin Sodium Phosphate Injection
    • Xi'an, Shaanxi, China
      Xijing Hospital
    Jan 30, 2023

    Hypertension Trial in Dongguan (Felodipine sustained release tablets (trade name: plendil®), Felodipine Controlled Release

    Active, not recruiting
    • Hypertension
    • Felodipine sustained release tablets (trade name: plendil®)
    • Felodipine Controlled Release Tablets
    • Dongguan, Guangdong, China
      Clinical Trial Centre of Dongguan Kanghua Hospital
    Jan 31, 2023

    ADHD Trial in Hollywood (Centanafadine)

    Completed
    • Attention Deficit Hyperactivity Disorder
    • Hollywood, Florida
      For additional information regarding sites, contact 844-687-8522
    Jun 1, 2022

    Smoking Cessation Trial in Charlotte, Raleigh (Centanafadine)

    Recruiting
    • Smoking Cessation
    • Charlotte, North Carolina
    • +1 more
    Sep 19, 2022

    Tension-Type Headache Trial in Rawalpindi (sustained natural apophyseal glides (SNAGS), suboccipital muscle release,

    Active, not recruiting
    • Tension-Type Headache
    • sustained natural apophyseal glides (SNAGS)
    • +2 more
    • Rawalpindi, Punjab, Pakistan
      Fauji Foundation Hospital
    May 22, 2023

    Liver Transplantation Trial (Tacrolimus Sustained-release Capsules)

    Not yet recruiting
    • Liver Transplantation
    • Tacrolimus Sustained-release Capsules
    • (no location specified)
    Nov 25, 2023

    Sarpogrelate, Blood Viscosity, Peripheral Arterial Disease Trial in Uijeongbu (Sarpogrelate Sustained Release/Aspirin, Aspirin)

    Recruiting
    • Sarpogrelate
    • +3 more
    • Sarpogrelate Sustained Release/Aspirin
    • Aspirin
    • Uijeongbu, Gyeonggi-do, Korea, Republic of
      The Catholic University of Korea Uijeongbu St. Mary's Hospital
    Feb 6, 2023

    Pain Trial (JAN101 SR, Placebo)

    Not yet recruiting
    • Pain
    • JAN101 SR
    • Placebo
    • (no location specified)
    May 30, 2023

    Somatic Symptom Trial in Shanghai (toludesvenlafaxine HCl sustained-release tablets)

    Not yet recruiting
    • Somatic Symptom
    • toludesvenlafaxine hydrochloride sustained-release tablets
    • Shanghai, Shanghai, China
      Shanghai Mental Health Center
    May 6, 2023

    Neuropathic Pain, Diabetes, Type 2 Trial in Korea, Republic of (pregabalin sustained release tablet, pregabalin immediate

    Active, not recruiting
    • Neuropathic Pain
    • Diabetes Mellitus, Type 2
    • pregabalin sustained release tablet
    • pregabalin immediate release capsule
    • Cheongju, Chungcheongbuk-do, Korea, Republic of
    • +7 more
    Nov 14, 2022

    Cerebral Small Vessel Diseases Trial in Beijing (Pentoxifylline sustained-release tablets, Pentoxifylline sustained-release

    Not yet recruiting
    • Cerebral Small Vessel Diseases
    • Pentoxifylline sustained-release tablets
    • Pentoxifylline sustained-release tablets placebo
    • Beijing, China
      Beijing Tiantan Hospital
    Oct 13, 2022

    Diabetic Macular Edema Trial (OXU-001, Semi-automated suprachoroidal illuminated microcatheter, Ozurdex® Ophthalmic Intravitreal

    Not yet recruiting
    • Diabetic Macular Edema
    • (no location specified)
    Jan 24, 2023

    Idiopathic Parkinson Disease Trial in Minneapolis (levodopa/carbidopa oral formulation A, levodopa/carbidopa oral formulation B,

    Not yet recruiting
    • Idiopathic Parkinson Disease
    • levodopa/carbidopa oral formulation A
    • +2 more
    • Minneapolis, Minnesota
      University of Minnesota
    Jul 20, 2022

    Renal Transplant Recipients Trial in China (Tacrolimus sustained-release capsule)

    Completed
    • Renal Transplant Recipients
    • Tacrolimus sustained-release capsule
    • Beijing, China
    • +8 more
    Jul 26, 2022